0001209191-18-004356.txt : 20180118 0001209191-18-004356.hdr.sgml : 20180118 20180118180305 ACCESSION NUMBER: 0001209191-18-004356 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180116 FILED AS OF DATE: 20180118 DATE AS OF CHANGE: 20180118 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SELICK HAROLD E CENTRAL INDEX KEY: 0001287233 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-51173 FILM NUMBER: 18534983 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CATALYST BIOSCIENCES, INC. CENTRAL INDEX KEY: 0001124105 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 562020050 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 260 LITTLEFIELD AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 6507450655 MAIL ADDRESS: STREET 1: 260 LITTLEFIELD AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: TARGACEPT INC DATE OF NAME CHANGE: 20000919 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-01-16 0 0001124105 CATALYST BIOSCIENCES, INC. CBIO 0001287233 SELICK HAROLD E 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080 1 0 0 0 Stock Option (Right to Buy) 157.20 2018-01-16 4 D 0 197 0.00 D 2020-05-13 Common Stock 197 0 D Stock Option (Right to Buy) 157.20 2018-01-16 4 A 0 197 0.00 A 2018-01-16 2020-07-11 Common Stock 197 197 D Stock Option (Right to Buy) 66.00 2018-01-16 4 D 0 550 0.00 D 2025-10-22 Common Stock 550 0 D Stock Option (Right to Buy) 66.00 2018-01-16 4 A 0 550 0.00 A 2018-01-16 2020-07-11 Common Stock 550 550 D Stock Option (Right to Buy) 66.00 2018-01-16 4 D 0 450 0.00 D 2025-10-22 Common Stock 450 0 D Stock Option (Right to Buy) 66.00 2018-01-16 4 A 0 450 0.00 A 2018-01-16 2020-07-11 Common Stock 450 450 D Stock Option (Right to Buy) 28.20 2018-01-16 4 D 0 500 0.00 D 2026-06-09 Common Stock 500 0 D Stock Option (Right to Buy) 28.20 2018-01-16 4 A 0 500 0.00 A 2018-01-16 2020-07-11 Common Stock 500 500 D Stock Option (Right to Buy) 4.40 2018-01-16 4 D 0 10000 0.00 D 2018-06-15 2027-07-13 Common Stock 10000 0 D Stock Option (Right to Buy) 4.40 2018-01-16 4 A 0 10000 0.00 A 2018-01-16 2020-07-11 Common Stock 10000 10000 D Reflects a fifteen-for-one reverse stock split on February 10, 2017. The option is fully vested and exercisable. The reported transactions involved an amendment to the post-termination exercise period of outstanding options, resulting in the deemed cancellation of the vested options and the grant of replacement fully vested options. /s/ Faisal Shawwa, Attorney-in-Fact for Harold E. Selick 2018-01-18